SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " agnos " 941 found 🔀 AI-powered Shuffle
Dangerous diagnoses turn heart patient into a heart health advocate
14-year fight to save his failing heart has meant a world of change for James Young II, who now works to help others save their hearts too.
The healthcare creator is finally diagnosing how they best fit into the creator economy
Healthcare creators are powerful brand partners, but they have to fit into the creator economy without sacrificing their credibility
NYC Health + Hospitals to Open Second Bridge to Home Facility in Brooklyn to Expand Transitional Housing Program for Unhoused New Yorkers Diagnosed with Serious Mental Illness - NYC Health + Hospitals
New York, NY – NYC Health + Hospitals today announced that it will expand the Bridge to Home program to Brooklyn, building on the success of the program's
In Good Health: Chronic Pelvic Pain In Women
Chronic pelvic and vulvovaginal pain is surprisingly common among women of all ages. In fact, 1 in 3 women will experience a pelvic floor disorder at some point in their lifetimes.So, why is it so difficult to receive diagnosis and treatment for these conditions? And why don’t we talk about our pain ‘down there’ in general?In this installment in our series, “In Good Health,” we sit down with a panel of experts to talk about it.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Inside Bruce Willis’ Health Journey: What to Know About the Actor’s Frontotemporal Dementia
Bruce Willis has been diagnosed with frontotemporal dementia, prompting his retirement from acting. Here’s everything to know about Bruce Willis’ health journey since his diagnosis.
Ebola, chemical plants and health, hantavirus, common colds, heat and more
As they say, bugs have ears. Public health has had a relentless May. Chemical plant (near) explosions, Ebola, hantavirus, and that's before you even get to the usual suspects: common colds, heat, and ticks. Here’s an attempt to keep you up to speed and, more importantly, what it means for you and your community. But first, an announcement: World Cup The World Cup starts in 15 days (not like anyone is counting down), and we are hanging TVs in the Health Security Operations Center. It’s going to be a gorgeous, chaotic celebration of basically every culture on earth. And it’s going to take a team effort—from communities to individuals, from public health to health care—to keep people healthy. That’s where you come in. If you’re going to the games or live within 30 miles of a stadium, we would love to hear from you. Sign up for a weekly survey here. Thanks to the more than 1,280 people who have already signed up…you will be hearing from us soon!! Global disease “weather report” Hantavirus: Two more cases The global count of cruise ship passengers with hantavirus has now increased to 13 cases (11 confirmed), with three deaths. The two new cases are overseas and among people who were already quarantining: A crew member in the Netherlands. A Spanish national passenger who was quarantining at home tested positive through daily monitoring. They are now in a biocontainment unit. In the U.S., everyone remains negative. There may be more cases, given that the incubation period of hantavirus (the time from exposure to infection) is 45 days. But this week, we will reach a major milestone: the median incubation window is 18 days, and that will pass on May 29. What this means for you: Your risk from this cruise ship outbreak remains essentially nil at this point. Ebola rages on in Central Africa Big thanks to Dr. Craig Spencer, a humanitarian physician who has treated and survived Ebola, for jumping in to provide the YLE community with an update. Craig, take it from here… The combined confirmed and suspected Ebola cases in DRC are now more than 1,000. All signs are pointing to a very long and catastrophic outbreak in Central Africa: This is a vast undercount. We know this because the test positivity rate is hovering around 50%, only 20% of contacts are being traced (and in some areas, no contacts at all), and more cases keep popping up with no known connection. This all points to widespread and undetected community transmission. This is in only a week of detection. Compared to previous outbreaks, the growth is very fast, as the huge West Africa outbreak in 2016 was first detected at 49 cases and rose to 208 cases a month later. It took four months for that outbreak to reach the size of the current one in the DR Congo. The cases are spread out across 16 health zones. There are now multiple epicenters, making containment very difficult. Next door in Uganda, the case count is seven. While this number is low compared to DRC, a concerning development is that two health care workers recently tested positive with uncertain exposure histories. If they weren’t treating known Ebola cases, this means it’s spreading undetected in Uganda as well. On the ground, backlash, including the burning of health centers, has emerged, a pattern seen in nearly every outbreak and rooted in deep community distrust. It often stems from outside actors working in communities without fully understanding or addressing local priorities. Affected populations may recognize the severity of Ebola while still holding other concerns as more pressing, such as where their loved ones are buried. Community trust is essential to an effective response, but difficult to build during an active emergency. It is best established long before a crisis begins. U.S. priorities are made clear, and may backfire. The U.S. Administration has shown that its first priority is keeping Ebola out, with helping end the outbreak in the DRC a secondary concern. That's meant travel restrictions broader than anything we've imposed before — covering travelers from across the region, and reportedly some green card holders and permanent residents as well. For example, just these past two days, news broke that high-risk American travelers will be subject to a mandatory quarantine in Kenya before they are allowed to return. If an American is infected, the U.S. government plans to send them to a hospital it is standing up from scratch in Kenya. (Currently, Americans who were in the area are allowed to return but are diverted to three airports—Houston, Atlanta, and DC—for further screening.) Past administrations have used travel notices and stepped-up screening; this goes much further. At first blush, these strict precautions may sound prudent. But this approach could backfire in three ways: Restrictions this blunt give people every reason to hide where they’ve been and whom they’ve been near — making the people we most need to find harder to track, not easier. They also breed a false sense that this is someone else’s problem. But diseases are humbling. They find the small cracks in even the most impenetrable-seeming defenses. Lives lost. There is no treatment for this Ebola strain, which means survival depends heavily on the quality of the health system. We have that system in the States, but we are choosing not to use it for infected Americans. This is unbelievable and infuriating. (See a deeper dive from me here.) The only real way to lower the risk to Americans — and everyone else — is to end the outbreak in the DRC and across the region. What this means for you: If you have travel plans to this region, it’s time to cancel them. This is a high-risk situation in Central Africa, and CDC released a Level 4 Travel Advisory. There is also great uncertainty if and when the Administration will let you back in. To the general public in the U.S., your risk remains very, very low right now. U.S. disease “weather report” Ticks: past peak season? Good news, especially for people in the Northeast and Midwest: tick numbers continue to decline. Though we are at the peak of the season, this unusually early year is trending favorably. Heat-related illnesses in the North Heat risk is certainly not blanketing the entire country yet, but this week it will be moderate in the Midwest and the Southeast. What this means for you: Be sure to check the CDC HeatRisk tool. A red day isn’t the best day for that soccer game for a kid with asthma, and a stretch of orange days is a great time to check on your elderly neighbor. Common colds surging As far as respiratory viruses go, the only thing really going around right now is the common cold. It is higher this year than last year, but should peak very soon before returning this fall. Spotlight: Chemical plants Over the weekend, YLE California covered the serious situation that unfolded around a chemical plant in Orange County, California. Thankfully, the worst-case scenario (a chemical explosion) was mitigated, but only through luck. The health implications in a densely populated area could have been catastrophic. As the situation was winding down, another chemical explosion struck Washington State. This one was fatal. Health officials say the risk to surrounding residents from chemicals in the air and ground remains low, though the community deserves far greater clarity. Clean air and clean water consistently rank as Americans’ top public health concerns — yet when chemical disasters strike, communities are too often met with reassurances rather than transparency and accountability. Residents near the 2023 East Palestine, Ohio train derailment, for example, are still waiting to understand the long-term impact on their health, with few clear answers. What this means for you: Many are wondering if facilities processing potentially dangerous materials are in their neighborhoods. This interactive map allows you to enter your ZIP code and see all facilities monitored by the EPA, including any violations. Good news Ebola vaccines and treatment for the Bundibugyo species are in development. Two vaccine platforms are being explored, at least one of which may be deployable in as little as 2 months. One vaccine is being developed by Oxford, and the other uses the same biotechnology as the FDA-approved Zaire species of Ebola. (It may provide cross-protection, but it’s unclear at this point.) On the treatment side, two promising monoclonal antibody cocktails are likely to be deployed, though doses are limited and logistical hurdles remain significant challenges. Anni over at The Biotech Tea had a great explainer about the Ebola vaccine gap, if you want to read more. [ The Biotech Tea The Ebola vaccine gap, reading vessel damage, & the Makary exit 🗝️ Paid subscribers get the Biotech Term of the Week at $30/year (~$2.50/month). I try to keep it intentionally accessible, but if cost is ever a barrier, send me a message. A few people asked about expensing your subscription, so I put together a short email template… Read more 6 days ago · 10 likes · Annicka Evans, PhD ](https://www.thebiotechtea.com/p/the-ebola-vaccine-gap-reading-vessel?utm_source=substack&utm_campaign=post_embed&utm_medium=web) Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS), following more than a decade of debate and input from roughly 22,000 clinicians, researchers, and patients worldwide. This is good because the old name was medically misleading, leading to patients without visible cysts being dismissed or overlooked entirely. The WHO estimates that 70% of people with the condition remain undiagnosed. A more accurate name should improve recognition, reduce stigma, and ultimately help the millions of people living with this condition get diagnosed and treated sooner. Poll Loading... Bottom line Public health situations are everywhere right now. Staying healthy takes public health professionals and systems working tirelessly behind the scenes and each of us showing up for our neighbors and communities. Love, YLE Big thanks to Ed Nirenberg for staying on top of the Ebola vaccines, Hannah Totte for all the figures, Dr. Craig Spencer for the Ebola insight, and Dr. Matt Willis for covering the chemical situation in CA. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Argentina coach Scaloni encouraged by news on Messi injury
Argentina coach Lionel Scaloni said the initial news regarding superstar Lionel Messi's fitness "is not that bad" and hopes further examinations will confirm that diagnosis with the World Cup just a fortnight away."Now one has to wait and see how it evolves and above all the new tests they are going to conduct in order to see if it confirms their original diagnosis."
FinTech Pet Care Software Kennel Connection Brings Petwealth Pet Health Diagnostics to Pet Boarding & Daycare Expo West Following Strong Industry Reception at Intergroom
MOORPARK, Calif., May 26, 2026--Kennel Connection expands its exclusive Petwealth diagnostics partnership to Pet Boarding & Daycare Expo West following strong reception at Intergroom
Girls with ADHD from deprived backgrounds may face a higher risk of long-term health conditions
Girls from a deprived background who are diagnosed with attention deficit hyperactivity disorder (ADHD) may be more likely to experience multiple long-term health conditions, or multimorbidity, in adulthood, ...
Aspira Women’s Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women’s Health
Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
BioTools Innovator selected 30 life science startups for its 2026 Accelerator, with companies competing for $300K in funding.
What To Expect After a Myositis Diagnosis
When you’re diagnosed with myositis, it can be a relief to finally know what’s behind your symptoms. But then what? Here’s what to expect.
Jardine to Buy Australian Imaging Firm I-MED in $2.4 Bilion Deal
Jardine Matheson Holdings Ltd. agreed to buy Australian medical diagnostic imaging provider I-MED Radiology Network Ltd. from private equity firm Permira, as the Asia-focused conglomerate seeks to expand its portfolio.
'We can identify these really early, before the clinical diagnosis': Epigenetic markers may help explain why Native Hawaiians are aging faster
Live Science spoke with Alika Maunakea, an Native Hawaiian epigeneticist, about how epigenetics underpins health disparities between Native Hawaiians and others in Hawaii.
Mental health, anxiety visits more common at Mass. pediatrician's offices
Visits for anxiety grew more than any other prominent mental health diagnosis.
Media, Democrats suggest politics behind Tulsi Gabbard's exit amid husband's cancer battle
The Daily Signal national correspondent Tony Kinnett discusses the response to Tulsi Gabbard's resignation due to her husband's diagnosis with a rare form of bone cancer.
Donald Trump Jr.’s Inner Circle Rallying Around Ex- Vanessa Amid Health Struggle
Donald Trump Jr.’s ex-wife, Vanessa Trump, is reportedly being surrounded by support from both her family and the wider Trump circle following her breast cancer diagnosis. Insiders close to the family...
Steam Controller Gets HID Remapper Support for 3rd-Party Compatibility
HID Remapper is an open-source, hardware-agnostic project that makes input devices remappable with a hardware USB adaptor that sits between the input device and the host device and converts inputs from the controller into a signal that is compatible with the host. According to a new May 20 update to...
Legionnaires' disease concerns at East Village housing complex prompts NYC Health Department response
New York City's Department of Health has launched an evaluation of East Village apartment complex after two residents were diagnosed with Legionnaires' disease over the course of a year.
Tulsi Gabbard Resigns as Trump’s Intelligence Chief
In her resignation letter, Gabbard says she is leaving her post as director of National Intelligence following her husband’s cancer diagnosis.
EXCLUSIVE: Tulsi Gabbard resigns from Trump Cabinet
Tulsi Gabbard notified President Trump she is resigning as DNI, citing her husband Abraham's diagnosis with an extremely rare form of bone cancer.
World Health Assembly endorses resolution on precision medicine
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on Precision medicine: a path towards targeted, personalized and equitable care, taking an important step towards advancing precision medicine as part of efforts to strengthen equitable, effective and sustainable health systems. Precision medicine refers to the use of clinical, molecular, genomic and other health data to inform prevention, diagnosis and treatment, taking into account variability while applying appropriate ethical and legal safeguards. When integrated responsibly into health systems, precision approaches can improve outcomes across different disease areas and across the life course – from cancer and rare diseases to infectious diseases, maternal, newborn and child health, mental health and noncommunicable diseases. The resolution reflects rapid advances in genomics, diagnostics, data science and digital health, alongside widening global inequities in access to these innovations. Many populations – particularly in low- and middle-income countries – remain underrepresented in data and research, limiting the public health impact of precision medicine and risking the widening of health disparities if action is not taken now. "Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world. But its benefits remain out of reach for too many and the research driving progress is concentrated in high income countries. This WHA resolution gives global health leaders, ministries of health, and WHO a clear mandate: to act. From infant screening to setting up genomic databases WHO will work with countries to bring about the power of these innovations." Dr Meg Doherty, Director Science for HealthThrough the resolution, Member States commit to developing and strengthening national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems, aligned with universal health coverage. This includes promoting affordability, ensuring inclusive research and data systems, strengthening regulation and data governance, and fostering collaboration across sectors and regions.WHO is requested to provide technical and normative support, review and coordinate existing guidance, facilitate global and regional collaboration, and develop a Global Strategy on Precision Medicine to guide equitable and context‑appropriate implementation. WHO stands ready to support Member States through tools such as a country maturity model for countries to self-assess capacity in implementing precision medicine depending on their context. In the immediate term WHO will map all existing guidance and frameworks and host extensive consultations with interest holders globally.By placing equity, inclusion and public value at the centre of precision medicine, the resolution reinforces WHO’s commitment to ensuring that scientific advances benefit all people, everywhere, and that no one is left behind in the next era of health innovation."By uniting people-centered healthcare with innovation, precision medicine has the potential to transform lives. This resolution helps ensure those advances serve the shared goal of health for all." Dr Sylvie Briand, Chief Scientist For further information please visit the Health Topic: Genomics
Diamondbacks 2, Rockies 1: Duel of the Fates
Zach Agnos shines on the mound as the Rox drop the series opener
Could the secret to diagnosing endometriosis be hiding in plain sight?
Although menstrual blood is typically discarded, researchers are beginning to use it to reveal new clues about women’s health.
Nearly 60% of college students with a psychosis diagnosis are not receiving the recommended mental health treatment
Despite a low overall prevalence of psychosis in the United States, affecting three percent of the population, this condition is a serious public health concern because people often delay seeking care ...
Why renaming this common hormonal disorder is a huge deal
You probably know someone who has a condition that, until last week, was known as PCOS, or polycystic ovary syndrome. It affects one in eight reproductive-aged women. But despite it being such a common disorder, patients are often misdiagnosed and have delayed treatment. Now, medical professionals are trying to change that. After 15 years of work, the condition has been renamed to PMOS, or polyendocrine metabolic ovarian syndrome. The new name reflects the real driver of the condition: disruptions in hormones. But how much can changing a name really do? Click here to access resources about PMOS in multiple languages. Interested in more science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
Primary Care Making More Mental Health Diagnoses for Kids
Pediatric mental health visits in primary care surged over a 9-year period.
Texas health officials report first human West Nile case of the year
A Texas resident has been diagnosed with West Nile neuroinvasive disease, a severe and relatively rare complication of the illness. It’s the first reported human case of West Nile in Texas this...
Barcelona Institute for Global Health: Expanded TB screening does not speed up treatment initiation or improve survival in hospitalised patients with HIV
Adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommended diagnostic approach.
A hidden barrier to starting a family
Endometriosis is a widespread disease affecting at least one in eight women, often leading to infertility, which can be prevented with earlier diagnosis and treatment.
Innovation Developed by UT Health Sciences Research Program Passes Landmark Trial for Cardiac Amyloidosis
A new diagnostic tool developed at the University of Tennessee Health Sciences may soon make it significantly easier for physicians to detect cardiac amyloidosis, a progressive and frequently underdiagnosed disease caused by abnormal protein deposits in the heart.
Reimagining mental health: Stanford Medicine experts chosen to lead precision task force
Stanford Medicine’s Leanne Williams was chosen to lead the Precision Mental Health Commission to redefine and streamline how psychiatric conditions are diagnosed and treated. She’s pushing for a data-driven approach that begins with brain imaging.
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports
Activist investor Elliott Investment Management has built a sizeable stake in U.S. diagnostics supplier Bio-Rad Laboratories NYSE:BIO, and plans to push the company to boost its underperforming stock price, the Wall Street Journal reported on Sunday.Bio-Rad's shares have fallen more than 18% so fa…
Open-Source "low_latency_layer" Brings Reflex & Anti-Lag 2 To AMD & Intel GPUs On Linux
A new open-source project called low_latency_layer is an implicit Vulkan layer that enables AMD Anti-Lag 2 and NVIDIA Reflex 2 to reportedly work in a hardware-agnostic manner so that AMD and Intel graphics cards can both enjoy Reflex or Anti-Lag 2 working on non-AMD graphics cards as well.
LSU LCMC Health Cancer Center reshapes healthcare with clinical trials that are at the forefront of medical innovation
For Denise Phipps, a frightening trip to the emergency room for chest pain turned into a diagnosis that could have easily stripped away hope.
Life with PMDD: 'Like the Grim Reaper coming every month'
Women diagnosed with premenstrual dysphoric disorder discuss how it impacts their lives.
My son died from colon cancer at 30; what I want young people to know
Kathy Lemoine's 30-year-old son, Andrew Reaster, died after he was diagnosed with stage 4 colon cancer. His main symptom was a stomach ache.
Women with this condition are often misdiagnosed. Its new name could help.
The PCOS name change to PMOS aims to reflect the full scope of the condition — and finally unlock the care women have been seeking for years.
PCOS Gets a New Name in Landmark Women's Health Shift
By HealthDay Staff HealthDay ReporterFRIDAY, May 15, 2026 (HealthDay News) — A major women’s health condition is getting a new name—and experts say it could change how millions are diagnosed and treated worldwide. Polycystic ovary syndrome, or PCOS, will now be known as polyendocrine metabolic ...
AI could transform healthcare if it focused on prevention
AI shows promise in healthcare by reducing admin, improving diagnosis, and boosting prevention through early detection and behavior change.
Netanyahu testifies his health is 'top decile' in libel suit over cancer reports
The Prime Minister Testified in Court After He Sued an Anti-government Activist and Two Journalists Over Reports on His Health. In April, a Medical Report Revealed Netanyahu Had Been Diagnosed With Prostate Cancer and Underwent Radiation Therapy Without Informing the Public in Real Time
Colon cancer is rising in young adults and doctors don’t fully know why
Colorectal cancer is increasingly showing up in younger adults, with cases now appearing in people as young as their thirties — often with no family history or warning signs. A major Swiss study analyzing nearly 100,000 cases over four decades found that diagnoses in people under 50 have been steadily climbing, even as rates fall among older adults thanks to screening programs. Researchers say younger patients are also more likely to be diagnosed late, after the cancer has already spread.
An Atlas of Mental Health
Mental health diagnoses can help, but human minds are more sophisticated than rigid categories. We may need better "maps," not just boxes, to understand mental health and illness.
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...
Sports surgeon discusses Yankees’ Max Fried’s initial elbow diagnosis
Going into Wednesday, Fried had a 2.91 ERA over nine starts, but his walks were slightly up and his strikeouts were slightly down from 2025.
Strengthening Colorado’s mental-health workforce
By Kyle Brown and Lindsay Gilchrist More than 1.2 million Coloradans live with a diagnosed mental health condition, and in 2023, one in five people seeking care were unable to get the treatment they needed. Overwhelmingly, insurance delays and inadequate provider networks are to blame. A recent study found credentialing for providers takes up to […]
How FMOL Health has positioned Baton Rouge at the forefront of sepsis diagnostics
FMOL Health has become the first health system in the world to deploy a breakthrough sepsis diagnostic technology across its entire network of hospitals. Executives say the Baton Rouge-developed i… Already an INSIDER? Sign in. Already an INSIDER? Sign in
Jason Collins, NBA's first openly gay player, dies of brain cancer at 47
Collins announced his diagnosis of stage 4 glioblastoma in December
Opinion | We’re Thinking About Mental Health Diagnoses All Wrong
Neither genetics nor brain scans can distinguish a person with depression, A.D.H.D. or autism from one without.
Mahomet business sells candles helping mom with cancer
MAHOMET, Ill. (WCIA) – One Mahomet business owner is using her shop to help others. Hairstylist and mother, Karley Bridgwater, was diagnosed with cancer for the second time. She works at Salon 105…
Eduardo Dominguez of VML Health on ‘Chasing the Miracles of Science’ for Sanofi
Eduardo is a global creative director with VML Health. His work includes the groundbreaking “Dogs Without Borders,” in which trained dogs detect cancer through scent, offering early diagnosis in remote regions such as the Amazon, the Sahara,and Los Pueblos Negros. Beyond his creative work, Eduardo regularly writes for medical sector magazines, sharing insights on enhancing Eduardo is a global creative director with VML Health. Over the course of his 10+ year career, he has worked with some of the industry's top talent, delivering projects that have helped improve the lives of thousands.His work includes the groundbreaking “Dogs Without Borders,” trained dogs to detect cancer through scent, offering early diagnosis in remote regions such as the Amazon, the Sahara, and Los Pueblos Negros.
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.
Siemens Healthineers shakes up leadership team, cuts profit outlook
The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment.
🗞️ Madrid in meltdown, Friday's back pages look like this
What should have been a week of preparation for Sunday’s Clásico has turned into Real Madrid’s biggest internal crisis in years. This Friday’s front pages all agree on a devastating diagnosis:...
Pat Caputo, longtime Detroit sports media fixture, FOX 2 contributor, dies after cancer battle
Caputo, 66, revealed in January that had been diagnosed with stage 4 pancreatic cancer.
OG Anunoby injury: Knicks forward diagnosed with hamstring strain, considered questionable for Game 3, day-to-day
More political interference at the FDA?
A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newsletter.
World Patient Safety Day 2025 Webinar on Goal 4: Prevent health care-associated infections
Webinar Series on the World Patient Safety Day GoalsSafe care for every newborn and every childPatient safety for newborns and children remains a critical global health priority. Children are particularly vulnerable to preventable harm due to developmental factors, dependency on caregivers, complex medication dosing requirements, diagnostic uncertainty, and increased susceptibility to health care-associated infections.Ensuring safe care for every newborn and every child is therefore essential to improving health outcomes and strengthening quality of care across health systems.The World Patient Safety Day 2025 campaign, under the theme:“Safe care for every newborn and every child: Patient safety from the start!”emphasizes the importance of embedding patient safety principles early in life and across the continuum of maternal, newborn and child health services.The campaign identifies five priority goals, calling for coordinated action by governments, health professionals, professional associations, civil society, and families globally.Webinar 4: “Prevent health care-associated infections”Thursday 7 May 2026, 14.00–15.30 CESTJoin this five-part webinar series on the Patient Safety Goals for safe care for every newborn and every child, featuring global experts and practitioners discussing real-world implementation, challenges, and solutions to reduce avoidable harm.The webinar will address the following topics:• Why infection prevention and control is essential for safe newborn and childcare• How Goal 4 can be implemented in practice at the point of care• What health care workers, leaders, managers, and policymakers can do to Prevent healthcare-associated infections.Registration linkDownload the flyer
Diagnostic dilemma: A woman turned black and blue weeks after starting a new medication
A woman's sudden hyperpigmentation was a side effect of a medicine she was taking.
A better path forward for cancer care - UT Health San Antonio
From the moment of diagnosis, UT Health San Antonio patients are connected to a system designed to expand their treatment possibilities and bring the full strength of medicine and research to their care. Specialized programs focus on common and rare cancers, which allows for more personalized treatment approaches. For those at increased risk, services such as cancer genetics counseling and risk-reduction clinics offer early insight and prevention strategies.
Lark Voorhies gives rare interview about 'Saved by the Bell,' Dustin Diamond's death
Lark Voorhies has given a rare interview about 'Saved by the Bell' and the death of her costar Dustin Diamond, after revealing she was diagnosed with schizoaffective disorder in 2015.
COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings
Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
4D mammo may be up to four times more accurate than 3D
The 4D system harnesses X-ray diffraction to measure molecular-level signatures of disease; these tissue “fingerprints” could help providers diagnose breast cancer in its earliest stages.
How Perimenopause Became America's New Health Scare
If you’re a woman who speaks English, it sometimes feels like you can’t spend time on the internet without being bombarded with all the ways in which your body or your mind could be just a little broken. A few years ago, Instagram was full of women talking about attention deficit disorder, and lo and behold: From 2020 to 2022, the percentage of women (between the ages of 23 and 49) newly diagnosed with it nearly doubled. Not long ago, premenstrual syndrome was all the rage, with the algorithm pushing videos that explained why it’s okay to fly off the handle once a month. These days, the word perimenopause is everywhere. Perhaps you’ve seen the headlines. “Perimenopause is having a millennial moment. Here are 7 ways to cope,” says The Washington Post. Or perhaps you’ve seen Apple TV’s glossy drama Your Friends & Neighbors, which is back for its second season; the female protagonist Mel is explicitly perimenopausal, and in the first season, she keyed a car for no apparent reason. She’s played by Amanda Peet, who talks about being perimenopausal in real life (“God knows I’ve wanted to key a lot of cars in the last three years,” she’s said.) In fact, it sometimes feels like every celebrity interview with a forty- or fiftysomething woman requires her to open up about what’s going on with her hormones. Drew Barrymore joked on CBS Mornings that when she found out how long perimenopause can last, she thought she’d “never make it 10 years like this.” Katherine Heigl told Business Insider that “whoever designed it so that women would be going through perimenopause while raising teenagers should be sent a strongly worded letter.” At the same time, influencers who talk about perimenopause seem to have cropped up out of nowhere with something to sell you, causing people online to wonder where this all came from. It’s trickled down from Instagram to tchotchke shops, which sell fridge magnets that say “Perimenopause Is Hot.” You can buy a T-shirt that proclaims “Perimenopause Made Me Do It!” My mom, who is 48, started uncontrollably shaking her leg at night a few years ago. “It’s perimenopause,” she told me when I complained about how annoying it was. But what exactly is perimenopause—and why are we all talking about it all of a sudden?
AI Can’t Solve America’s Diagnosis Crisis
MAHA wants to automate health care — while gutting the rest of the system.
Death of health reporter Liz Bonis shocks WKRC-TV coworkers
Bonis was a private person who kept her colon cancer diagnosis secret for three years at Channel 12.
AI Can Spot Pancreatic Cancer Years Before Diagnosis, Study Finds
Catching this deadly disease while it's treatable can save lives.
As artificial intelligence show off diagnostic chops, scientists reckon with the way forward
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical reasoning tasks.
Can AI help doctors avoid missed diagnoses? A new study suggests yes
AI may help doctors avoid missed diagnoses, but it still needs real-world testing and human oversight before it can guide patient care.
Integrated Counselors: Bringing mental health to the physical world - Choctaw Nation of Oklahoma
Choctaw Nation Behavioral Health provides integrated counselors in clinic settings to support patients experiencing emotional distress, difficult diagnoses, or needing support during medical visits.
Brain scans reveal 3 ADHD subtypes, including a more extreme form
A study analyzing 1,154 children and adolescents breaks new ground in how to think about the growing diagnosis.
Damon Wayans reveals the scary symptom that led to his type 2 diabetes diagnosis
Damon Wayans details his type 2 diabetes journey, the symptoms that alarmed him and his new partnership to raise awareness for the diabetic eye disease DME.
Redeem the Time: What Ben Sasse Teaches Us About Life, Death, and Politics
Sasse has a lot of hard-earned wisdom to impart, including some that only comes when facing a terminal diagnosis. He’s inviting us to walk with him through that dark valley.
Astorg buys Thermo Fisher Microbiology business
Astorg has agreed to acquire Thermo Fisher Scientific’s microbiology business, creating a standalone diagnostics platform backed by private equity investment.
AI Tool May Spot ADHD Years Before Children Are Diagnosed
DURHAM, N.C. — Attention-deficit/hyperactivity disorder (ADHD) affects millions of children, yet many go years without a diagnosis, missing the chance for early support that can change long-term outcomes even when early signs are present.
'This is Me.' Autism diagnosis did not stop me from telling my story
I was diagnosed with autism at the start of sixth grade. Here's my story of how I got to journalism and now Vermont.
Early attention deficit hyperactivity disorder prediction from longitudinal electronic health records
Nature Mental Health - Using electronic health records from over 140,000 children, the authors developed a neural network model that predicts attention deficit hyperactivity disorder diagnosis...
'Who is taking care of us?': Childcare workers can't afford insurance
Andreya Chapman's job is her passion. But it's also why she's struggled to afford health coverage, an issue that pushed off a cancer diagnosis.
Ms. Rivera goes to Washington — to advocate for liver health
Through years of monitoring, a cancer diagnosis and two liver transplants, Rivera found a passion for liver health advocacy.
Timberwolves' Donte DiVincenzo reportedly diagnosed with torn Achilles, Anthony Edwards undergoing testing on knee
Brain-Gut Health Initiative supports AI-assisted diagnosis of psychiatric disorders
Psychiatric disorders affect millions worldwide, but their diagnosis still relies on clinical observation instead of standard biological tests.
Nan Schaffer, veterinarian who helped unlock the science of rhino reproduction, has died, aged 72
“One of the great tragedies of the 21st century,” Nan Schaffer once said, “will be humanity’s homogeneity.” The remark was less a warning than a diagnosis. In a world where landscapes were being simplified and species reduced to remnants, she concerned herself with what would be lost when difference itself began to disappear. For species […]
Carrie Ann Inaba shares her struggle to manage hidden, invisible illness: 'It's real'
Carrie Ann Inaba shares her silent struggle with Sjogren's disease, an autoimmune condition that she says went undiagnosed for more than 10 years.
A flawed diagnosis of Cuban health care
Progressives who praise communist systems just prove how gullible they are.
Snooki reveals regrets after cancer diagnosis (exclusive)
After being diagnosed with cervical cancer, Nicole 'Snooki' Polizzi is opening up on her big health regret.
Apex High senior makes return to soccer after cancer diagnosis
After being diagnosed with Hodgkin lymphoma her senior year, an Apex High student is back on the field — and finishing the season she once thought was over.
I was a triathlete in peak health — but my 'wavy' vision problem turned out to be something devastating
After her cancer misdiagnosis, Lucy Liu advocates for early screening
Lucy Liu shares how a misdiagnosis led to surgery and changed how she advocates for her own health.
UNE’s fourth Health Care Story Slam puts a human face on chronic illness
UNE’s fourth Health Care Story Slam on April 15 put a human face on chronic illness and the long road to diagnosis as seven speakers took the stage to explore this year's theme of balance in the Harold Alfond Forum on UNE's Biddeford Campus.
Advancing epidemic and pandemic preparedness through research readiness: SEAR Unity Studies Network Sites chart the way forward in 2026
On 25 March 2026, WHO Regional Office for the South‑East Asia Region (SEARO) convened the first meeting of the SEAR Chapter of the Unity Studies Network Meeting in 2026 to take stock of progress and plan next steps for strengthening epidemic and pandemic preparedness across the Region. The meeting focused on reviewing the ongoing adaptation of selected, standard Unity Study methodologies, sharing field implementation experiences from 2025, and identifying key priorities to guide collaborative work in 2026.Held virtually, the meeting brought together representatives from six Unity Studies network sites across five countries (Bangladesh, India, Nepal, Sri Lanka, and Thailand) as well as participants from all three levels of WHO.The meeting took place against the backdrop of ongoing regional efforts in South‑East Asia to strengthen early investigations and studies for epidemic and pandemic preparedness, with a focus on pandemic influenza and other emerging respiratory pathogens with epidemic and pandemic potential. In this context, and as part of preparedness for the rapid generation of evidence, the WHO Health Emergencies Programme in SEAR (WHE/SEAR) encourages Unity Studies sites to adapt prioritized, standardized Unity Study protocols to their national contexts. This approach supports the generation of timely and reliable evidence to inform public health decision‑making during epidemics and pandemics.These efforts are supported through a combination of experience sharing, participation in the global Unity Studies network webinars, capacity‑building of the national public health workforce, and regional collaboration that promotes inter‑country, inter‑agency, and inter‑ministerial action. In parallel, sites are encouraged to explore diversified funding sources to help sustain research preparedness over the long term.Discussions highlighted the importance of WHO’s catalytic financial support through the Pandemic Influenza Preparedness (PIP) Partnership Contributions (PIP‑PC). When combined with national and institutional resources, this support enables countries and sites to maintain continuity of activities at a core level and remain prepared to respond rapidly and effectively to future epidemics and pandemics.Regional and Global Updates: Opening the session, Dr Pushpa Ranjan Wijesinghe, Programme Area Manager, Pandemic and Epidemic Management (PEM) Unit, WHO Health Emergencies Programme, highlighted the progress made in operationalizing the Unity Studies Network across the Region and acknowledged the collaborative efforts of WHO at all three levels, together with country unity studies sites. He emphasized the availability of limited but catalytic funding through the Pandemic Influenza Preparedness (PIP) Partnership Contribution (PIP‑PC) workplan at SEARO to sustain network activities in 2026, while encouraging sites to leverage additional funding sources to expand implementation.Representing SEARO, Dr Ashok Basnet, consultant, Pandemic Influenza Preparedness reported that, at the regional level, the Unity Studies Network currently includes six sites across five countries: Bangladesh, India, Nepal, Sri Lanka, and Thailand. He noted that in 2025, catalytic funding supported protocol adaptation, training, and pilot implementation. In addition, a regional Unity Studies symposium held during the Global Public Health Summit in Sri Lanka strengthened and advocated collaboration between the Unity Studies site, national decision‑making forum, relevant technical units of the ministry of health, WHO and other partners.The symposium also highlighted the role of early investigations and studies as a key component of a multi‑source surveillance system needed at country level to generate a broad range of evidence. It underscored the critical role of country Unity Studies sites and similar research entities in generating evidence to support public health decision‑making during epidemics and pandemics.Participants of the WHO GISRS Unity Studies Sites Network- SEAR Chapter Meeting 2026 (Photo credit- PEM/WHE/SEARO). SEARO also updated participants on ongoing efforts to develop a regional Unity Studies webpage and to promote participation in global knowledge‑sharing platforms, including webinars and the WHO Community of Practice. Priorities for 2026 include supporting the implementation of Unity protocols, strengthening collaboration and experience sharing across sites, documenting and publishing findings, integrating Unity Studies activities as a component of multi-source national surveillance systems, and building workforce capacity.Dr Nickle Boddington of the Global Influenza Programme (GIP) at WHO Headquarters, which coordinates the Unity Studies Network globally, provided updates on global Unity Studies activities, noting that the network has expanded to 16 sites worldwide. New and updated protocols, including rapid clinical severity assessment tools and standardized data platforms, are being developed to support implementation. The global Community of Practice has also been launched to facilitate technical exchange, and continued support will be provided to sites for protocol adaptation, ethical approvals, and readiness for early investigation during outbreaks. Updates from Unity Studies sites in SEAR in 2025Unity Studies sites shared progress and experiences in implementing protocols across diverse country contexts. Sites initiated activities in 2025 using catalytic funding from SEARO, complemented by the mobilization of internal national resources. The Institute of Epidemiology, Disease Control and Research (IEDCR), Bangladesh, reported the adoption and piloting of investigation protocols on non‑seasonal influenza and emerging respiratory diseases during recent avian influenza outbreaks, demonstrating a multi‑source funding approach involving government, WHO and One Health partners.The Hamdard Institute of Medical Sciences and Research (HIMSR), New Delhi, India, highlighted the piloting of household transmission investigation studies, the expansion of the national Unity Studies network, and the contribution of study findings to global evidence through published outputs. The All-India Institute of Medical Sciences (AIIMS), New Delhi, India, shared experiences from large‑scale seroprevalence studies conducted during the COVID‑19 pandemic, recent efforts to strengthen national Unity network sites through training activities, and plans to initiate multi‑centre studies on respiratory viruses.Similarly, Prince of Songkla University, Thailand, highlighted its experience in developing integrated surveillance and diagnostic protocols for multiple respiratory pathogens, enhancing readiness for targeted investigations of emerging threats. The University of Sri Jayewardenepura, Sri Lanka, reported ongoing engagement with the Ministry of Health and exploration of additional funding sources to initiate studies. Meanwhile, the National Public Health Laboratory, Nepal, provided updates on continued coordination with national stakeholders to initiate implementation, despite delays related to the country context.Across sites, shared experiences underscored the importance of protocol adaptation, multisectoral collaboration, and sustainable funding to operationalize Unity Studies and generate evidence for public health action.Discussions and Way ForwardThe meeting reinforced key priorities for 2026, including strengthening unity studies protocol implementation, enhancing collaboration, knowledge sharing, integrating research as a component of national multi-source surveillance systems, and ensuring that generated evidence informs public health decision‑making. Participants also emphasized the importance of documentation, visibility, and leveraging multiple funding sources, and agreed on the following action points.Unity Studies Sites and WHO Country Offices:Advance adoption and implementation of at least one Unity protocol, continuing activities initiated in 2025 with catalytic funding, supplemented with other sources of funding where feasible.Document site-specific experiences, outcomes, and lessons learned; participate in regional and global knowledge-sharing platforms including WHO webinars and the Community of Practice.Work closely with ministries of health to establish unified national platforms for translating generated evidence into national public health decision-making. WHO Country Offices may facilitate technical support and complementary, synergistic funding opportunities where feasible. WHO Regional OfficeCoordinate with WHO Country Offices to support implementation of core unity studies activities by network sites through catalytic funding and provide technical guidance and virtual engagement opportunities throughout 2026.Facilitate the participation of all Unity Studies sites in the regional meeting on Unity Studies implementation in October 2026, to be held back‑to‑back with the Annual SEAR Regional PIP‑PC Meeting; develop and host a SEAR Unity Studies website; and mobilize support from academic institutions within the SEAR Unity Studies Network to support the development of regional manuscripts that showcase Unity Studies activities to scientific audiences and promote knowledge‑sharing.Explore complementary funding opportunities and partnerships to sustain and expand network activities across the Region.WHO HeadquartersProvide global technical guidance, updated protocols, and toolkits to support the implementation of Unity Studies in SEAR.Facilitate engagement of SEAR sites in global webinars, the Community of Practice, and opportunities to showcase their work.Support joint publications, inclusion of SEAR experiences in global outputs, and identification of additional funding and collaborative opportunities to strengthen Unity Studies activities.
Cancer
WHO fact sheet on cancer providing information on the health burden of different types of cancer, causes, risk factors, prevention, early diagnosis, treatment, palliative care, and WHO's work in this area.
Radiology Business Management Association elects new board members
Stacy Sanso—director of patient access for ARA Diagnostic Imaging, the Austin, Texas, affiliate of Radiology Partners—takes over as president of the association.
Re:Cognition Health Delivers Landmark International Clinical Trial to Explore Whether a Simple Finger-prick Blood-based Biomarker Test Can Provide Earlier Alzheimer's Diagnosis
Re:Cognition Health, a global leader in new treatments for Alzheimer's Disease, is delivering an international clinical trial to evaluate whether a simple finger-prick blood test can revolutionize how Alzheimer's disease is diagnosed. Compared with the current invasive and expensive diagnostic methods, this approach could provide a scalable solution for an earlier, easier, more accurate, affordable, and accessible diagnostic method. Re:Cognition Health will help enroll approximately 1,000 partic
Radiology Business Management Association names new board of directors
Stacy Sanso—director of patient access for ARA Diagnostic Imaging, the Austin, Texas, affiliate of Radiology Partners—takes over as president of the association.
After his own diagnosis, New Orleans Broadway star starts foundation for children with Type 1 diabetes
Kyle Banks was diagnosed with Type 1 diabetes during his Broadway tour of Disney's The Lion King after months of struggling with symptoms. Now, the New Orleans native wants to give back to his roots by providing resources for Louisiana children and families living with the disease.
A new way to detect life beyond Earth without knowing what life looks like
Researchers from the Earth-Life Science Institute (ELSI) and National Institute for Basic Biology have developed a new method to detect extraterrestrial life without relying on traditional biosignatures. By modelling how life might spread between planets, they demonstrate that life could be detected through statistical patterns across planetary populations rather than on individual planets. This "agnostic biosignature" approach could assist in guiding future searches for life beyond Earth.